Alamar Biosciences, Inc.
ALMR
$29.36
-$0.60-1.99%
NASDAQ
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | 13.03% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 13.03% | ||||
| Cost of Revenue | 1.13% | ||||
| Gross Profit | 22.56% | ||||
| SG&A Expenses | 26.45% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 11.92% | ||||
| Operating Income | -9.60% | ||||
| Income Before Tax | 36.28% | ||||
| Income Tax Expenses | -120.04% | ||||
| Earnings from Continuing Operations | 38.11% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 38.11% | ||||
| EBIT | -9.60% | ||||
| EBITDA | -10.89% | ||||
| EPS Basic | 87.06% | ||||
| Normalized Basic EPS | 79.71% | ||||
| EPS Diluted | 87.06% | ||||
| Normalized Diluted EPS | 79.71% | ||||
| Average Basic Shares Outstanding | 378.52% | ||||
| Average Diluted Shares Outstanding | 378.52% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||